Research has shown that SOX2, a member of the SOX gene family, plays a role in promoting small-cell transformation in prostate cancer with RB1/TP53 mutations and in the transformation of EGFR-mutant lung adenocarcinoma. This evidence concerns the gene SOX2 and prostate carcinoma.